Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | -43.3% | -41.9% | -31.5% | 31.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT margin | -1583.2% | -515.2% | -85.7% | 25.9% | 9.7% |
| Pre-tax income | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.3% | 1.9% | 6.6% | 13.3% | 2.7% |
| Net income | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | -1487.3% | -405.5% | -69.1% | 20.0% | 8.0% |
| |
| Diluted EPS | ($2.58) | ($1.39) | ($0.85) | $0.32 | $0.01 |
| Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|